Caris Graham Number from 2010 to 2026

CAI Stock  USD 26.50  0.49  1.88%   
Caris Life's Graham Number is increasing with stable movements from year to year. Graham Number is predicted to flatten to 20.53. For the period between 2010 and 2026, Caris Life, Graham Number quarterly trend regression had mean deviation of  8.92 and range of 52.8638. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
33.19
Current Value
20.53
Quarterly Volatility
12.49238049
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Latest Caris Life's Graham Number Growth Pattern

Below is the plot of the Graham Number of Caris Life Sciences over the last few years. It is Caris Life's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Pretty Stable
   Graham Number   
       Timeline  

Caris Graham Number Regression Statistics

Arithmetic Mean32.87
Geometric Mean28.87
Coefficient Of Variation38.00
Mean Deviation8.92
Median36.88
Standard Deviation12.49
Sample Variance156.06
Range52.8638
R-Value0.27
Mean Square Error154.59
R-Squared0.07
Significance0.30
Slope0.66
Total Sum of Squares2,497

Caris Graham Number History

2026 20.53
2025 33.19
2020 36.88
2019 38.61
2018 56.19
2017 49.66
2016 12.86

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's Graham Number, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Graham Number 33.19  20.53 

Currently Active Assets on Macroaxis

When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.